Genome Editing in Drug Discovery. Группа авторов

Читать онлайн.
Название Genome Editing in Drug Discovery
Автор произведения Группа авторов
Жанр Биология
Серия
Издательство Биология
Год выпуска 0
isbn 9781119671398



Скачать книгу

between the crRNA and target RNA at the central seed sequence is essential for binding and then stimulating RNase activity (Abudayyeh et al. 2016; Tambe et al. 2018), whereas peripheral mismatches are tolerated to a greater extent. Further elements are also needed for activation of RNase activity of the HEPN domains. Sequence and structure of the hairpin are critical, where reducing the length under 24 nt or mutating key nucleotides significantly decreased its activity (Abudayyeh et al. 2016; Smargon et al. 2017). Analogous to PAM, Cas13 also requires protospacer flanking site (PFS) proximal to the target site; the exact sequence and position is dependent on the subtype and species. For example, Cas13a requires a 3’ non‐G PFS, while Cas13b need a PFS at either side of the protospacer, with the 5’ being depleted of C and the 3’ PFS having a consensus sequence of NAN or NNA, where N is any nucleotide (Abudayyeh et al. 2016, Smargon et al. 2017).

      3.3.3 Adaptation

      The last phase of the CRISPR‐mediated immunity that shall be addressed here is the adaptation phase, also known as spacer acquisition. In this phase, the memory of previous infections is recorded, allowing an organism and its descendants to confer immunity to the reinvading genome. The CRISPR array acts as a genetic ledger, with spacers acting as records of infections (with the most recent usually located closest to the leader sequence). The key players in spacer acquisition are Cas1 and Cas2, present in nearly every CRISPR system. In contrast to the ubiquity of these genes, understanding of molecular mechanisms of adaptation is restricted just to type I and type II systems with many mechanistic details still missing, with more studies needed to elucidate this process in its entirety.

      The latter phase of adaptation is mediated by highly conserved Cas1:Cas2 adaptation complex. However, some CRISPR systems also require additional proteins, such as Csn2 and Cas9 of S. pyogenes type II system (Heler et al. 2015; Wei et al. 2015), or Cas4 of type I and type V systems (Lee et al. 2018). Furthermore, in certain species with type III and type VI systems, fusions of cas1 and reverse transcriptase (RT) genes have been discovered (Silas et al. 2016; Gonzalez‐Delgado et al. 2019; Toro et al. 2019), and then shown to be able to insert spacers originating from RNA and DNA, where the integration of RNA is followed by cDNA synthesis by the RT domain (Silas et al. 2016; Gonzalez‐Delgado et al. 2019).

      The adaptation complex is composed of the central Cas2 dimer flanked on either side by a Cas1 dimer (Figure 3.6d). The captured DNA fragments (termed prespacer DNA) are bound by the central Cas2 dimer, with the Tyr22 of the E. coli Cas1 acting as a protein wedge to splay open the bound dsDNA fragment (Nunez et al. 2014; Nunez et al. 2015). The splayed ends of the bound prespacer DNA can be trimmed by host’s DnaQ 3’‐5’ exonuclease‐domain containing enzymes (such as DNA polymerase III, exonuclease T, DnaQ, or in some species by Cas2‐DnaQ fusion proteins) into fragments with 5 nt overhangs (Kim et al. 2020; Ramachandran et al. 2020), which are optimal for integration into CRISPR locus (Nuñez et al. 2015). In some CRISPR systems, trimming can be performed by Cas4, a RecB nuclease domain‐containing protein (Lee et al. 2018). Either way, the length of the prespacer DNA is maintained at the fixed length by the distance between two Cas1 subunits flanking Cas2 dimer, ensuring a uniform length of spacers within the CRISPR array. Finally, the 3’ ends are positioned into the active sites of Cas1, making them poised for catalysis at CRISPR array.

      While the interactions between Cas1:Cas2 complex and protospacer DNA are through phosphate backbone rather than base‐specific interactions, the selection of specific protospacers by the adaptation machinery is often nonrandom. Spacers are preferentially acquired from sequences proximal to PAM sites (Savitskaya et al. 2013), with the adaptation complex in E. coli type I system able to select functional prespacers by directly recognizing the PAM sequence (Datsenko et al. 2012; Swarts et al. 2012; Wang et al. 2015). Similarly, the aforementioned Cas4 also seems to have a key role in selecting prespacers (Rollie et al. 2018). Furthermore, recognizing the PAM sequence is also used to orient the prespacer into CRISPR array so that the crRNA ultimately contains the correct sequence necessary for recognition (Shiimori et al. 2018).

      Crucially, while PAM is used to identify functional prespacers and position them in the correct orientation, it must be removed prior to integration into CRISPR array; otherwise, it will induce self‐immunity. This is achieved by removing the PAM sequence immediately prior to integration, either by the exonucleases (Ramachandran et al. 2020) or Cas4 (Lee et al. 2019). By coupling recognition of functional PAM sites with the prespacer processing increases the chance of integrating a functional spacer that will be compatible with future interference phases.

Schematic illustration of adaptation phase(s) in CRISPR system.